Valuation: Iqvia Holdings Inc.

Capitalization 34.01B 32.51B 30.68B 26.96B 48.26B 2,955B 53.55B 364B 135B 1,234B 127B 125B 5,160B P/E ratio 2025 *
24.8x
P/E ratio 2026 * 20.9x
Enterprise value 45.94B 43.92B 41.44B 36.41B 65.19B 3,992B 72.33B 492B 182B 1,666B 172B 169B 6,970B EV / Sales 2025 *
2.89x
EV / Sales 2026 * 2.67x
Free-Float
67.55%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.15%
1 week-6.68%
Current month-4.08%
1 month-2.13%
3 months+0.24%
6 months-19.40%
Current year-1.71%
More quotes
1 week
192.10
Extreme 192.1
200.28
1 month
192.10
Extreme 192.1
220.00
Current year
192.10
Extreme 192.1
220.00
1 year
187.62
Extreme 187.62
261.73
3 years
165.75
Extreme 165.75
261.73
5 years
81.79
Extreme 81.79
285.61
10 years
55.01
Extreme 55.011
285.61
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 2016-10-02
Director of Finance/CFO 64 2020-07-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 67 2015-02-04
Director/Board Member 59 2007-12-31
Chairman 64 2016-10-02
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-0.15%-6.68%-19.05%-14.67% 34.06B
-2.73%-3.27%+28.07%-4.63% 48.26B
-0.66%+0.73%+3.91%+23.44% 26.71B
+0.61%+7.87%+73.63%+86.50% 16.54B
+1.31%-1.15%-34.73%-17.96% 15.37B
-8.37%+19.88% - - 14.08B
+8.37%+12.17%-59.55%-75.57% 12.7B
-0.99%-6.62%-8.83%-34.41% 10.42B
+0.17%-3.88%-12.99%+139.54% 10.36B
+0.35%-0.17%-9.66%-23.34% 8.62B
Average +0.10%+1.01%-4.36%+8.77% 19.71B
Weighted average by Cap. -0.44%+0.36%+2.34%+5.38%
See all sector performances

Financials

2025 *2026 *
Net sales 15.92B 15.22B 14.36B 12.62B 22.59B 1,383B 25.07B 170B 63.2B 578B 59.67B 58.49B 2,416B 16.89B 16.15B 15.23B 13.39B 23.97B 1,468B 26.59B 181B 67.05B 613B 63.31B 62.05B 2,563B
Net income 1.44B 1.38B 1.3B 1.14B 2.04B 125B 2.27B 15.41B 5.72B 52.22B 5.4B 5.29B 218B 1.67B 1.6B 1.51B 1.33B 2.37B 145B 2.63B 17.91B 6.64B 60.67B 6.27B 6.14B 254B
Net Debt 11.93B 11.4B 10.76B 9.46B 16.93B 1,036B 18.78B 128B 47.35B 433B 44.71B 43.82B 1,810B 11.02B 10.53B 9.94B 8.73B 15.64B 957B 17.35B 118B 43.74B 400B 41.3B 40.48B 1,672B
More financial data * Estimated data
Logo Iqvia Holdings Inc.
Iqvia Holdings Inc. is one of the world's leading companies specializing in information, analytics, research and healthcare services based on technology solutions. Net sales break down by activity as follows: - development of contract research and clinical development solutions and services (55.4%): helping biopharmaceutical companies, medical researchers and healthcare professionals optimize their clinical studies, develop new therapeutic classes, identify treatment needs and assess the efficacy of pharmaceuticals with a view to improving clinical and scientific outcomes; - development of technology and analytics solutions (39.9%): services related to information, analysis, strategic consulting, marketing studies and short-term healthcare-market studies, business processes outsourcing, and management of medical-administrative databases, all aimed at optimizing the performance and commercial strategies of pharmaceutical companies and health workers; - integrated services (4.7%): development and implementation of customized solutions and customer engagement programs, healthcare services, scientific and medical services, etc. Net sales are distributed geographically as follows: Americas (47.8%), Europe and Africa (31.9%) and Asia/Pacific (20.3%).
Employees
88,000
More about the company
Date Price Change Volume
25-02-18 193.15 $ -0.15% 1,438,799
25-02-14 193.44 $ -1.33% 1,527,629
25-02-13 196.05 $ -0.89% 905,690
25-02-12 197.82 $ -1.53% 1,044,006
25-02-11 200.89 $ -2.94% 1,380,704

Delayed Quote Nyse, February 18, 2025 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
193.15USD
Average target price
247.60USD
Spread / Average Target
+28.19%
Consensus

Quarterly revenue - Rate of surprise